<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=DDI2</id>
	<title>DDI2 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=DDI2"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=DDI2&amp;action=history"/>
	<updated>2026-04-08T02:56:04Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=DDI2&amp;diff=6358&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «DDI1 homolog 2 (EC 3.4.23.-)  ==Publications==  {{medline-entry |title=Androgen receptor polyglutamine expansion drives age-dependent quality control defects and...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=DDI2&amp;diff=6358&amp;oldid=prev"/>
		<updated>2021-05-12T15:26:24Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «DDI1 homolog 2 (EC 3.4.23.-)  ==Publications==  {{medline-entry |title=Androgen receptor polyglutamine expansion drives age-dependent quality control defects and...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;DDI1 homolog 2 (EC 3.4.23.-)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29809168&lt;br /&gt;
|abstract=Skeletal muscle has emerged as a critical, disease-relevant target tissue in spinal and bulbar muscular atrophy, a degenerative disorder of the neuromuscular system caused by a CAG/polyglutamine (polyQ) expansion in the androgen receptor ([[AR]]) gene. Here, we used RNA-sequencing (RNA-Seq) to identify pathways that are disrupted in diseased muscle using [[AR]]113Q knockin mice. This analysis unexpectedly identified substantially diminished expression of numerous ubiquitin/proteasome pathway genes in [[AR]]113Q muscle, encoding approximately 30% of proteasome subunits and 20% of E2 ubiquitin conjugases. These changes were age, hormone, and glutamine length dependent and arose due to a toxic gain of function conferred by the mutation. Moreover, altered gene expression was associated with decreased levels of the proteasome transcription factor [[NRF1]] and its activator [[DDI2]] and resulted in diminished proteasome activity. Ubiquitinated [[ADRM1]] was detected in [[AR]]113Q muscle, indicating the occurrence of stalled proteasomes in mutant mice. Finally, diminished expression of Drosophila orthologues of [[NRF1]] or [[ADRM1]] promoted the accumulation of polyQ [[AR]] protein and increased toxicity. Collectively, these data indicate that [[AR]]113Q muscle develops progressive proteasome dysfunction that leads to the impairment of quality control and the accumulation of polyQ [[AR]] protein, key features that contribute to the age-dependent onset and progression of this disorder.&lt;br /&gt;
|mesh-terms=* Aging&lt;br /&gt;
* Animals&lt;br /&gt;
* Cell Adhesion Molecules&lt;br /&gt;
* Intracellular Signaling Peptides and Proteins&lt;br /&gt;
* Male&lt;br /&gt;
* Mice&lt;br /&gt;
* Mice, Transgenic&lt;br /&gt;
* Muscle, Skeletal&lt;br /&gt;
* Muscular Atrophy, Spinal&lt;br /&gt;
* Nuclear Respiratory Factor 1&lt;br /&gt;
* Peptides&lt;br /&gt;
* Proteasome Endopeptidase Complex&lt;br /&gt;
* Receptors, Androgen&lt;br /&gt;
* Trinucleotide Repeat Expansion&lt;br /&gt;
|keywords=* Muscle Biology&lt;br /&gt;
* Neuromuscular disease&lt;br /&gt;
* Neuroscience&lt;br /&gt;
* Protein misfolding&lt;br /&gt;
* Ubiquitin-proteosome system&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063498&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>